In March 2019, Prof Gabriele Bergers (VIB) gave an oral presentation entitled "Constructing tumor vessels to enhance immunity" at the Keystone Symposia Conference - Cancer Metastasis: The Role of Metabolism, Immunity and the Microenvironment.
Prof Bergers also travelled to the American Association of Cancer Research (AACR) 2019 to talk about how the Induction of high-endothelial venules in cancer can improve immunotherapy. In April Prof Bergers discussed "Studying and Targeting the Tumor Microenvironment in Intra-Heterogeneous Glioblastoma" at the Cold Spring Harbor Laboratory Meeting "Glioblastoma: Why is impactful science so hard to translate?"
Prof Martine Lamfers (EMC) spoke at the 2019 Annual meeting of the Royal Dutch Society of Microbiology and Netherlands Association for Medical Microbiologists about the clinical translation of the oncolytic adenovirus Delta24-RGD for treatment of glioblastoma. Prof Lamfers travelled to Boston in April 2019 to talk at the PEGS Boston Inaugural Oncolytic Viral Therapy Summit. Here Prof Lamfers spoke about about the development of patient-derived glioblastoma model systems to predict response to OV therapy. She then attended the Neuro-Oncology Meeting, Brigham and Women's Hospital/Dana Farber Cancer Institute Neuro-Oncology Conference held Harvard Medical School, Boston MA to discuss the development of patient-derived in vitro glioblastoma models for treatment selection.
April was a busy month for the GLIOTRAIN PIs, with Prof Simone Niclou (LIH) travelling to the European Society for Radiotherapy and Oncology (ESTRO) 38 Congress to give a talk entitled "Transcriptional response to temozolomide in Glioblastoma reveals critical role of long non-coding RNAs".
During the summer, Prof Bergers attended the British Association of Cancer Research (BACR) Tumour Microenvironment Meeting 2019 in the UK to present a talk entitled "Creating an immune-stimulating tumor microenvironment: From vessel pruning to vessel tuning". Prof Niclou discussed "Functional tumor banking" at the EANO Summer School 2019; Essential (molecular) neuropathology for Neuro-oncologists, endorsed by EURO-CNS.